Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome

Tissue Antigens

Volumn 61, Issue 2, 2003, Pages 166-171

  Quelvennec, E ^a   Bera, O ^b   Cabre, P ^c   Alizadeh, M ^a   Smadja, D ^c   Jugde, F ^a   Edan, G ^d   Semana, G ^a,e  

^a UNIVERSITÉ DE RENNES 1   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

^d PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^e Inst de Rech Contre le Cancer IRCC   (France)

Author keywords

Genetics; Histocompatibility complex; Multiple sclerosis; Myelin basic protein; Peptide presentation

Indexed keywords

AUTOANTIGEN; HLA DR ANTIGEN; MYELIN BASIC PROTEIN; PEPTIDE;

ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HLA SYSTEM; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MARTINIQUE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ALLELES; CASE-CONTROL STUDIES; CELL LINE; GENE FREQUENCY; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MARTINIQUE; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; T-LYMPHOCYTES;

EID: 0037880597     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0001-2815.2002.00008.x     Document Type: Article

References (27)

1. Martin R, MacFarland HF, MacFarlin DE. Immunological aspects of demyelinating diseases. An Rev Immunol 1992: 10: 153-87.
2. Ebers GC, Sadovnick AD. The role of genetic factors in multiple sclerosis susceptibility. J Neuro Immunol 1994: 54: 1-17.
3. Ebers GC, Sadovnick Ad Risch NJ, Canadian Collaborative Study Group. A genetic basis for familial aggregation in multiple sclerosis. Nature 1995: 377: 150-1.
4. Munford CJ, Wood NW, Kellar-Wood H, Thorpe JW, Miller DH, Compston DA. The British Isles survey of multiple sclerosis in twins. Neurology 1994: 44: 11-5.
5. The Multiple Sclerosis Genetic Group. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nature Genet 1996: 13: 469-71.
6. Sawcer S, Jones HB, Feakes R et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nature Genet 1997: 13: 464-8.
7. Tiwari JL, Terasaki PI, Multiple Sclerosis. Tiwari JL, Terasaki PI, eds. HLA. and Disease Associations. New York: Springer-Verlag, 1985: 152-67.
8. Nepom GT, ErlichH. MHC class II molecules and autoimmunity. Annu Rev Immunol 1991: 9: 493-525.
9. Bera O, Semana G, Cesaire R et al. HLA class I and class II allele and haplotype diversity in Martinicans. Tissue Antigens 2001: 57: 200-7.
10. Cabre P, Heinzlef O, Merle H et al. MS and neuromyelitis optica in Martinique (French West Indies). Neurology 2001: 56: 507-14
11. Poser CM, Paty DQ, Scheinberg L et al. New diagnostic criteria for multiple sclerosis. Guidelines for Research Protocol.. Ann Neurol 1983: 13: 227-31.
12. Miller SA, Dykes DD, Poleski HF. Simple salting out procedure for extracting DNA from nucleated cells. Nucl Acids Res 1988: 16: 1215.
13. Semana G, Gausling R, Jackson JA, Hafler DA. T cell autoreactivity to proinsulin epitopes in diabetic patients and healthy subjects. J Autoimmun 1999: 12: 259-67.
14. Yang SY, Milford E, Hammerling U, Dupont B. Description of the reference panel of B-lymphoblastoïd cell lines for factors of the HLA system: the B cell line panel designed for the Tenth International Histocompatibility Workshop. Dupont B, Ed. Immunobiology of HLA. New York: Springer. Verlag, 1989: 1: 11-8.
15. Yaouanq J, Semana G, Eichenbaum S et al. Evidence for linkage disequilibrium between HLA-DRB1 gene and multiple sclerosis. The French Research Group on Genetic Susceptibility to MS. Science 1997: 276: 665.
16. Vartdal F, Sollid LM, Vandvik B, Markussen G, Thorsby E. Patients with multiple sclerosis garry DQB1 genes which encode shared polymorphic amino acid sequence. Hum Immunol 1989: 25: 103-10.
17. Spurkland A, Ronningen KS, Vandvik B, Thorsby E, Vartdal F. HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop Multiple Sclerosis. Hum Immunol 1991: 30: 69-75.
18. Haegert DG, Francis GS. HLA-DQ polymorphisms do not explain HLA class II associations with multiple sclerosis in two Canadian patient groups. Neurology 1993: 43: 1207-10.
19. Francis DA, Thompson AJ, Brookes P et al. Multiple sclerosis and HLA. Is the susceptibility gene really HLA-DR or -DQ? Hum Immunol 1991: 32: 119-24.
20. Serjeantson SW, Gao X, Hawkins BR, Higgins DA, Yu YL, Novel HLA-DR2-related haplotypes in Hong Kong Chinese implicate the DQB1*0602 allele in susceptibility to multiple sclerosis. Eur J Immunogenet 1982: 19: 11-9.
21. Hafler DA, Benjamin DS, Burks J, Weiner HL. Myelin basic protein and proteolipid protein reactivity of brain and cerebrospinal fluid-derived T cell clones in multiple sclerosis and post infections. J Immunol 1987: 139: 68-72.
22. Allegreta M, Nicklas JA, Sriram S, Albertini RJ. T cell responsive to multiple sclerosis Science 1990: 247: 718-21.
23. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA. T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis. Nature 1990: 346: 183-7.
24. Wucherpfennig KW, Sette A, Southwood S et al. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J Exp Med 1994: 179: 279-90.
25. Smith KJ, Pyrdol J, Gauthier L, Wiley DC, Wucherpfennig KW. Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein. J Exp Med 1998: 8: 1511-20.
26. Kuchroo V, Sobel RA, Yamamura T, Greenfield E, Dorf ME, Less MB. Induction of experimental allergic encephalomyelitis by myelin proteolipid-protein-specific T cell clones and synthetic peptides. Pathobiology 1991: 59: 305-12.
27. Johns TG, Kerlero de Rosbo N, Menon KK et al. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J Immunol 1995: 154: 5536-41.